Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Breast Cancer

  Free Subscription


Articles published in Am J Surg

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    March 2020
  1. SUTTON TL, Johnson N, Schlitt A, Gardiner SK, et al
    Surgical timing following neoadjuvant chemotherapy for breast cancer affects postoperative complication rates.
    Am J Surg. 2020 Mar 10. pii: S0002-9610(20)30146.
    PubMed     Text format     Abstract available


  2. BALISKI C, Hamm J
    Does receipt of preference sensitive care impact patient reported outcomes following breast cancer surgery?
    Am J Surg. 2020 Mar 10. pii: S0002-9610(20)30145.
    PubMed     Text format     Abstract available


  3. CUI X, Zhu C, Chen P, Qu M, et al
    Effect of pectoral nerve block type II under general anesthesia on the immune function of patients with breast cancer.
    Am J Surg. 2020 Mar 8. pii: S0002-9610(20)30150.
    PubMed     Text format     Abstract available


    February 2020
  4. LIU C, Cheifetz R, Brown C, Nichol A, et al
    Do surgeons convey all the details? A provincial assessment of operative reporting for breast cancer.
    Am J Surg. 2020 Feb 29. pii: S0002-9610(20)30134.
    PubMed     Text format     Abstract available


  5. FENG Y, He XG, Zhou CM, Zhang QY, et al
    Comparison of hepatic resection and systemic treatment of breast cancer liver metastases: A propensity score matching study.
    Am J Surg. 2020 Feb 28. pii: S0002-9610(20)30125.
    PubMed     Text format     Abstract available


  6. GOONAWARDENA J, Yong C, Law M
    Use of indocyanine green fluorescence compared to radioisotope for sentinel lymph node biopsy in early-stage breast cancer: systematic review and meta-analysis.
    Am J Surg. 2020 Feb 7. pii: S0002-9610(20)30069.
    PubMed     Text format     Abstract available


    January 2020
  7. CHA J, McKevitt E, Pao JS, Dingee C, et al
    Access to surgery following centralization of breast cancer surgical consultations.
    Am J Surg. 2020 Jan 31. pii: S0002-9610(20)30055.
    PubMed     Text format     Abstract available


  8. SROUR MK, Lee M, Walcott-Sapp S, Kim S, et al
    Thirty-day postoperative morbidity in patients with breast cancer following neoadjuvant chemotherapy.
    Am J Surg. 2020 Jan 22. pii: S0002-9610(20)30035.
    PubMed     Text format     Abstract available


    December 2019
  9. AGBORBESONG O, Helmer SD, Reyes J, Strader LA, et al
    Breast cancer treatment in the elderly: Do treatment plans that do not conform to NCCN recommendations lead to worse outcomes?
    Am J Surg. 2019 Dec 5. pii: S0002-9610(19)31558.
    PubMed     Text format     Abstract available


  10. HANGGE PT, Jogerst K, Mohsen A, Kosiorek H, et al
    Making an informed choice: Which breast reconstruction type has the lowest complication rate?
    Am J Surg. 2019;218:1040-1045.
    PubMed     Text format     Abstract available


    November 2019
  11. TSAI C, Zhao B, Chan T, Blair SL, et al
    Treatment for occult breast cancer: A propensity score analysis of the National Cancer Database.
    Am J Surg. 2019 Nov 11. pii: S0002-9610(19)31361.
    PubMed     Text format     Abstract available


  12. CROWN A, Rocha FG, Grumley JW
    Intraoperative radiation therapy in early-stage breast cancer: Presence of lobular features is not associated with increased rate of requiring additional therapy.
    Am J Surg. 2019 Nov 11. pii: S0002-9610(19)31293.
    PubMed     Text format     Abstract available


  13. BREIT C, Ablah E, Ward M, Okut H, et al
    Breast cancer risk assessment in patients who test negative for a hereditary cancer syndrome.
    Am J Surg. 2019 Nov 7. pii: S0002-9610(19)31492.
    PubMed     Text format    


    October 2019
  14. BREIT C, Ablah E, Ward M, Okut H, et al
    Breast cancer risk assessment in patients who test negative for a hereditary cancer syndrome.
    Am J Surg. 2019 Oct 11. pii: S0002-9610(19)30840.
    PubMed     Text format     Abstract available


  15. NAYYAR A, Strassle PD, Reddy KG, Jameison DI, et al
    Variations in the utilization of immediate post-mastectomy breast reconstruction.
    Am J Surg. 2019;218:712-715.
    PubMed     Text format     Abstract available


    August 2019
  16. CALDERON E, Webb C, Kosiorek HE, Richard J Gray MD, et al
    Are we choosing wisely in elderly females with breast cancer?
    Am J Surg. 2019 Aug 10. pii: S0002-9610(19)30354.
    PubMed     Text format     Abstract available


    July 2019
  17. KILLELEA BK, Gallagher EJ, Feldman SM, Port E, et al
    The effect of modifiable risk factors on breast cancer aggressiveness among black and white women.
    Am J Surg. 2019 Jul 18. pii: S0002-9610(19)30187.
    PubMed     Text format     Abstract available


  18. PLICHTA JK, Thomas SM, Sergesketter AR, Greenup RA, et al
    Clinical and pathological stage discordance among 433,514 breast cancer patients.
    Am J Surg. 2019 Jul 18. pii: S0002-9610(19)30099.
    PubMed     Text format     Abstract available


  19. BROMAN K, Sun W, Zhou JM, Fridley B, et al
    Outcomes of selective whole breast irradiation following lumpectomy with intraoperative radiation therapy for hormone receptor positive breast cancer.
    Am J Surg. 2019 Jul 17. pii: S0002-9610(19)30270.
    PubMed     Text format     Abstract available


    June 2019
  20. JAMES TA, Kasumova G, Alapati A, Mamtani A, et al
    Unplanned readmissions following breast cancer surgery.
    Am J Surg. 2019 Jun 20. pii: S0002-9610(19)30436.
    PubMed     Text format     Abstract available


  21. RANA S, Naik A, Pillai S, Vetto J, et al
    Outcomes of intraoperative radiotherapy for early-stage breast cancer: Experience from a multidisciplinary breast oncology program.
    Am J Surg. 2019 Jun 18. pii: S0002-9610(19)30332.
    PubMed     Text format     Abstract available


    April 2019
  22. JAY M, Creelman B, Baliski C
    Patient reported outcomes associated with surgical intervention for breast cancer.
    Am J Surg. 2019 Apr 17. pii: S0002-9610(18)31307.
    PubMed     Text format     Abstract available


    March 2019

  23. Effect of wound complications following mastectomy with reconstruction on breast cancer recurrence.
    Am J Surg. 2019;217:519.
    PubMed     Text format    



  24. The impact of obesity on treatment choices and outcomes in operable breast cancer.
    Am J Surg. 2019;217:478.
    PubMed     Text format    


    January 2019
  25. CHATTERJEE A, Asban A, Jonczyk M, Chen L, et al
    A cost-utility analysis comparing large volume displacement oncoplastic surgery to mastectomy with free flap reconstruction in the treatment of breast cancer.
    Am J Surg. 2019 Jan 31. pii: S0002-9610(18)31174.
    PubMed     Text format     Abstract available


  26. SATYANANDA V, Ozao-Choy J, Dauphine C, Chen KT, et al
    Effect of the Affordable Care Act on breast cancer presentation at a safety net hospital.
    Am J Surg. 2019 Jan 17. pii: S0002-9610(18)31369.
    PubMed     Text format     Abstract available


    November 2018
  27. BURKHEIMER E, Starks L, Khan M, Oostendorp L, et al
    The impact of obesity on treatment choices and outcomes in operable breast cancer.
    Am J Surg. 2018 Nov 14. pii: S0002-9610(18)30972.
    PubMed     Text format     Abstract available


    October 2018
  28. VALENTE SA, Liu Y, Upadhyaya S, Tu C, et al
    The effect of wound complications following mastectomy with immediate reconstruction on breast cancer recurrence.
    Am J Surg. 2018 Oct 16. pii: S0002-9610(18)31027.
    PubMed     Text format     Abstract available


    September 2018
  29. PUGH AM, Giannini CM, Pinney SM, Hanseman DJ, et al
    Characteristics and diagnosis of pregnancy and lactation associated breast cancer: Analysis of a self-reported regional registry.
    Am J Surg. 2018 Sep 20. pii: S0002-9610(18)30115.
    PubMed     Text format     Abstract available


    August 2018
  30. WAZIR U, Mokbel L, Wazir A, Mokbel K, et al
    Optimizing adjuvant endocrine therapy for early ER+ breast cancer: An update for surgeons.
    Am J Surg. 2018 Aug 3. pii: S0002-9610(18)30269.
    PubMed     Text format     Abstract available


    July 2018
  31. NAYYAR A, Strassle PD, Shen MR, Black JA, et al
    Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection.
    Am J Surg. 2018 Jul 24. pii: S0002-9610(18)30024.
    PubMed     Text format     Abstract available


  32. SCHWARTZBERG BS, Chin DT, Dorn PL, Herron DS, et al
    Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
    Am J Surg. 2018 Jul 19. pii: S0002-9610(18)30097.
    PubMed     Text format     Abstract available


  33. PARVEZ E, Cornacchi SD, Fu E, Hodgson N, et al
    Adoption and outcomes of radioguided seed localization for non-palpable invasive and in-situ breast cancer at three academic tertiary care centers.
    Am J Surg. 2018 Jul 9. pii: S0002-9610(18)30445.
    PubMed     Text format     Abstract available


    April 2018
  34. PARK VY, Kim EK, Moon HJ, Yoon JH, et al
    Value of ultrasound-guided fine needle aspiration in diagnosing axillary lymph node recurrence after breast cancer surgery.
    Am J Surg. 2018 Apr 21. pii: S0002-9610(17)31185.
    PubMed     Text format     Abstract available


  35. CANDELARIA RP, Hansakul P, Thompson AM, Le-Petross H, et al
    Analysis of stereotactic biopsies performed on suspicious calcifications identified within 24 months after completion of breast conserving surgery and radiation therapy for early breast cancer: Can biopsy be obviated?
    Am J Surg. 2018;215:693-698.
    PubMed     Text format     Abstract available


  36. KOZICK Z, Hashmi A, Dove J, Hunsinger M, et al
    Disparities in compliance with the Oncotype DX breast cancer test in the United States: A National Cancer Data Base assessment.
    Am J Surg. 2018;215:686-692.
    PubMed     Text format     Abstract available


    March 2018
  37. MASSIMINO K
    Discussion of: "Pre-surgical chemotherapy for breast cancer may be associated with improved outcome".
    Am J Surg. 2018 Mar 20. pii: S0002-9610(17)31659.
    PubMed     Text format    


  38. JOHNSON N
    Discussion of: Routine shave margins are not necessary in early stage breast cancer treated with breast conserving surgery.
    Am J Surg. 2018 Mar 20. pii: S0002-9610(18)30404.
    PubMed     Text format    


  39. COOK M, Johnson N
    Pre-surgical chemotherapy for breast cancer may be associated with improved outcomes.
    Am J Surg. 2018 Mar 16. pii: S0002-9610(17)31537.
    PubMed     Text format     Abstract available


  40. WILSON LL
    LaSalle D. Leffall and disparities in breast cancer.
    Am J Surg. 2018 Mar 7. pii: S0002-9610(18)30343.
    PubMed     Text format    



  41. Discussion of: Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Am J Surg. 2018;215:513-514.
    PubMed     Text format    



  42. Discussion of: A novel modality for intraoperative margin assessment and its impact on re-excision rates in breast conserving surgery.
    Am J Surg. 2018;215:404-405.
    PubMed     Text format    


  43. KUPSTAS A, Ibrar W, Hayward RD, Ockner D, et al
    A novel modality for intraoperative margin assessment and its impact on re-excision rates in breast conserving surgery.
    Am J Surg. 2018;215:400-403.
    PubMed     Text format     Abstract available


    February 2018
  44. WARREN SL, Bhutiani N, Agle SC, Martin RCG 2nd, et al
    Differences between palpable and nonpalpable tumors in early-stage, hormone receptor-positive breast cancer.
    Am J Surg. 2018 Feb 17. pii: S0002-9610(17)31373.
    PubMed     Text format     Abstract available


  45. DEBARROS M
    The significance and impact of pathogenic and variants of unknown significance (VUS) mutations in breast cancer patients and their treatment decisions.
    Am J Surg. 2018 Feb 15. pii: S0002-9610(17)31692.
    PubMed     Text format    


  46. HENRY-TILLMAN RS
    The tale of two stories: Challenges and innovations in breast cancer management.
    Am J Surg. 2018 Feb 1. pii: S0002-9610(17)31767.
    PubMed     Text format     Abstract available


    January 2018
  47. PAJAK C, Pao J, Ghuman A, McKevitt EC, et al
    Routine shave margins are not necessary in early stage breast cancer treated with Breast Conserving Surgery.
    Am J Surg. 2018 Jan 16. pii: S0002-9610(17)31640.
    PubMed     Text format     Abstract available


  48. SUTTON T, Reilly P, Johnson N, Garreau JR, et al
    Breast cancer in women under 50: Most are not high risk.
    Am J Surg. 2018 Jan 11. pii: S0002-9610(17)31563.
    PubMed     Text format     Abstract available


  49. LABGAA I, Slankamenac K, Schadde E, Jibara G, et al
    Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study.
    Am J Surg. 2018;215:125-130.
    PubMed     Text format     Abstract available


  50. RHEE D, Pockaj B, Wasif N, Stucky CC, et al
    Operative outcomes of conventional specimen radiography versus in-operating room specimen radiography in radioactive seed-localized segmental mastectomies.
    Am J Surg. 2018;215:151-154.
    PubMed     Text format     Abstract available


    December 2017
  51. HEELAN GLADDEN AA, Sams S, Gleisner A, Finlayson C, et al
    Re-excision rates after breast conserving surgery following the 2014 SSO-ASTRO guidelines.
    Am J Surg. 2017;214:1104-1109.
    PubMed     Text format     Abstract available


  52. VELAZCO CS, Wasif N, Pockaj BA, Gray RJ, et al
    Radioactive seed localization for breast conservation surgery: Low positive margin rate with no learning curve.
    Am J Surg. 2017;214:1091-1093.
    PubMed     Text format     Abstract available


  53. CHANG JM, Kosiorek HE, Wasif N, Gray RJ, et al
    The success of sentinel lymph node biopsy after neoadjuvant therapy: A single institution review.
    Am J Surg. 2017;214:1096-1101.
    PubMed     Text format     Abstract available


    November 2017
  54. TSUNG K, Grobmyer SR, Tu C, Abraham J, et al
    Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Am J Surg. 2017 Nov 14. pii: S0002-9610(17)30998.
    PubMed     Text format     Abstract available


  55. QU LT, Peters S, Cobb AN, Godellas CV, et al
    Considerations for sentinel lymph node biopsy in breast cancer patients with biopsy proven axillary disease prior to neoadjuvant treatment.
    Am J Surg. 2017 Nov 13. pii: S0002-9610(17)31018.
    PubMed     Text format     Abstract available


    October 2017
  56. ABBOTT AM, Valente SA, Loftus L, Tendulkar RD, et al
    A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?
    Am J Surg. 2017;214:629-633.
    PubMed     Text format     Abstract available


  57. BUCKLEY EJ, Zahnd WE, Rea DJ, Mellinger JD, et al
    Impact of rural-urban status on survival after mastectomy without reconstruction versus mastectomy with reconstruction.
    Am J Surg. 2017;214:645-650.
    PubMed     Text format     Abstract available


  58. NURUDEEN S, Guo H, Chun Y, Coopey S, et al
    Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers.
    Am J Surg. 2017;214:687-694.
    PubMed     Text format     Abstract available


    September 2017
  59. CHAGPAR A
    Discussion of Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Am J Surg. 2017 Sep 30. pii: S0002-9610(17)31379.
    PubMed     Text format    


  60. CHAGPAR AB
    On baseball and breast cancer.
    Am J Surg. 2017 Sep 20. pii: S0002-9610(17)31086.
    PubMed     Text format     Abstract available


  61. CHAGPAR AB, Horowitz N, Sanft T, Wilson LD, et al
    Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Am J Surg. 2017 Sep 19. pii: S0002-9610(17)30420.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: